Adenosine A2A receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease-Reference-Cited by-同舟云学术

Adenosine A2A receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease

Published:2004-01 Issue:1 Volume:127 Page:223-231
ISSN:0306-4522
Container-title:Neuroscience
language:en
Short-container-title:Neuroscience

Author:

Ochi M,Shiozaki S,Kase H

Publisher

Elsevier BV

Subject

General Neuroscience

Reference50 articles.

1. The functional anatomy of basal ganglia disorders;Albin;Trends Neurosci,1989

2. Adenosine A2A receptor antagonist treatment of Parkinson's disease;Bara-Jimenez;Neurology,2003

3. Evidence suggesting secondary epileptogenic lesions after kainic acid;Ben-Ari;Brain Res,1979

4. Mechanism of action of deep brain stimulation;Benazzouz;Neurology,2000

5. The primate subthalamic nucleus;Bergman;Neuronal activity in the MPTP model of Parkinsonism. J Neurophysiol,1994

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Balance Between Projecting Neuronal Populations of the Nucleus Accumbens Controls Social Behavior in Mice;Biological Psychiatry;2024-01

2. Balance between direct and indirect pathways of the nucleus accumbens controls social behavior in mice;2022-11-28

3. Blockade of adenosine A2A receptors inhibits Tremulous Jaw Movements as well as expression of zif-268 and GAD65 mRNAs in brain motor structures;Behavioural Brain Research;2022-01

4. Istradefylline – a first generation adenosine A2A antagonist for the treatment of Parkinson’s disease;Expert Review of Neurotherapeutics;2021-02-22

5. The challenge of developing adenosine A2A antagonists for Parkinson disease: Istradefylline, preladenant, and tozadenant;Parkinsonism & Related Disorders;2020-11